Quest PharmaTech (QPT) Insider Trading & Ownership C$0.03 +0.01 (+20.00%) (As of 11/1/2024 05:43 PM ET) Add Compare Share Share Insider Trades Stock AnalysisChartEarningsHeadlinesInsider Trades Quest PharmaTech (CVE:QPT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage17.06%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)C$4,570.30Number OfInsiders Selling(Last 3 Years)0 Get QPT Insider Trade Alerts Want to know when executives and insiders are buying or selling Quest PharmaTech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address QPT Insider Buying and Selling by Quarter Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Quest PharmaTech Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/15/2023Ragupathy MadiyalakanDirectorBuy15,290C$0.07C$1,070.308/29/2023Ragupathy MadiyalakanDirectorBuy30,000C$0.07C$2,100.008/25/2023Ragupathy MadiyalakanDirectorBuy20,000C$0.07C$1,400.00 (Data available from 1/1/2013 forward) QPT Insider Trading Activity - Frequently Asked Questions Who is on Quest PharmaTech's Insider Roster? The list of insiders at Quest PharmaTech includes Ragupathy Madiyalakan. Learn more on insiders at QPT. What percentage of Quest PharmaTech stock is owned by insiders? 17.06% of Quest PharmaTech stock is owned by insiders. Learn more on QPT's insider holdings. Which Quest PharmaTech insiders have been buying company stock? The following insider purchased QPT shares in the last 24 months: Ragupathy Madiyalakan (C$4,570.30). How much insider buying is happening at Quest PharmaTech? Insiders have purchased a total of 65,290 QPT shares in the last 24 months for a total of C$4,570.30 bought. Quest PharmaTech Key ExecutivesDr. Ragupathy Madiyalakan Ph.D.CEO & DirectorMr. Pierre Vermette C.A.CPA, Chief Financial OfficerMr. Roger AndrewsHead of Investor Relations & Corporate CommunicationsMr. Douglas C. Bachman (Age 70)Vice President of Corporate Development Compensation: $37.94kMr. Thomas WooVice President of Product Development More Insider Trading Tools from MarketBeat Related Companies Kane Biotech Insider Ownership Antibe Therapeutics Insider Ownership Aptose Biosciences Insider Ownership Hemostemix Insider Ownership Innovotech Insider Ownership Fennec Pharmaceuticals Insider Ownership Medicenna Therapeutics Insider Ownership Oncolytics Biotech Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Big Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics PartnersInsider Selling is not a Signal to Start Selling Gartner Stock2 Stocks to Buy and 1 to Sell - Smart Moves for Investors3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside This page (CVE:QPT) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quest PharmaTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quest PharmaTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free QPT Stock Alerts